The potential move by Donald Trump and Attorney General Todd Blanche to reclassify medical marijuana from Schedule I to Schedule III could mark one of the most significant regulatory shifts in the history of the U.S. cannabis industry. For operators, investors, and lenders—especially those working with Upwise Capital—this change isn’t...








